A phase one trial of a multivariant COVID-19 Vaccine has been launched by US pharmaceutical company Gritstone in collaboration with The University of Manchester and Manchester University NHS ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback